,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2019-07-30 06:45:00,"The stock market opened down on Tuesday morning, led lower by concerns that trade negotiations between the U.S. and China might not be going as well as investors had hoped.",0.021160637959837914,0.9676346778869629,0.011204656213521957,negative,-0.946474015712738
1,2019-07-30 06:45:00,"As of 10:30 a.m. EDT, the Dow Jones Industrial Average (DJINDICES: ^DJI) was down 71 points to 27,150.",0.0199858620762825,0.9628143906593323,0.017199760302901268,negative,-0.9428285360336304
2,2019-07-30 06:45:00,"The S&P 500 (SNPINDEX: ^GSPC) fell 11 points to 3,010, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) gave up 36 points to 8,257.",0.028794266283512115,0.9511102437973022,0.020095447078347206,negative,-0.9223159551620483
3,2019-07-30 06:45:00,"Despite the pressure on the broader market, some good news on the earnings front came through.",0.9103508591651917,0.030603593215346336,0.05904557928442955,positive,0.8797472715377808
4,2019-07-30 06:45:00,"Procter & Gamble (NYSE: PG) and Merck (NYSE: MRK) both saw gains after releasing their latest results, and their performance shows that there are pockets of strength even as concerns about economic conditions start to ramp up.",0.9485747814178467,0.020064491778612137,0.03136071935296059,positive,0.928510308265686
5,2019-07-30 06:45:00,Shares of Procter & Gamble jumped 4% after the consumer products giant reported its fiscal fourth-quarter financial results.,0.9270758628845215,0.024317987263202667,0.04860621690750122,positive,0.9027578830718994
6,2019-07-30 06:45:00,The company managed to post organic sales growth of 7% -- a pace that's been extremely difficult for such a large player in the space to achieve lately.,0.9535992741584778,0.019809506833553314,0.026591211557388306,positive,0.9337897896766663
7,2019-07-30 06:45:00,"P&G said that total revenue increased 4% compared to prior-year levels, even with the company facing a 4-percentage-point headwind from the strong U.S. dollar.",0.9583097100257874,0.02411084622144699,0.017579447478055954,positive,0.9341988563537598
8,2019-07-30 06:45:00,Organic growth came in part from a 3% rise in shipment volumes and in part from Procter & Gamble using its pricing power to boost its pricing by 3 percentage points.,0.9552151560783386,0.01705084554851055,0.027733907103538513,positive,0.9381642937660217
9,2019-07-30 06:45:00,Yet the consumer giant also pulled some other levers to produce growth.,0.8686897158622742,0.018517157062888145,0.1127932220697403,positive,0.8501725792884827
10,2019-07-30 06:45:00,"The company has tried to emphasize sales of premium brands like its SK-II high-end skin care line, and P&G's results showed favorable shifts in product mix that suggest that its strategy is working.",0.9368436932563782,0.014546099118888378,0.04861026257276535,positive,0.9222975969314575
11,2019-07-30 06:45:00,"Many headlines discussing Procter & Gamble will focus on a writedown of the Gillette business, which led the company to post a loss as reported under generally accepted accounting principles (GAAP).",0.021862657740712166,0.8467728495597839,0.13136442005634308,negative,-0.8249101638793945
12,2019-07-30 06:45:00,"However, P&G looks like it's doing well overall, and its efforts to try to restart its growth engines look strong as it moves into a new fiscal year.",0.934203028678894,0.017868386581540108,0.04792851582169533,positive,0.9163346290588379
13,2019-07-30 06:45:00,"Elsewhere, Merck saw its stock climb more than 2%.",0.9382928013801575,0.0354471392929554,0.026260042563080788,positive,0.9028456807136536
14,2019-07-30 06:45:00,"The drugmaker reported strong second-quarter financial results, buoyed largely by its oncology and human health vaccines businesses.",0.9510816931724548,0.019350480288267136,0.029567761346697807,positive,0.9317312240600586
15,2019-07-30 06:45:00,"Overall, Merck's revenue rose 12% from year-ago levels, powered higher by a 58% jump in sales of cancer-fighter Keytruda.",0.9588948488235474,0.022095080465078354,0.0190100260078907,positive,0.9367997646331787
16,2019-07-30 06:45:00,"Greater adoption of the human papillomavirus vaccine Gardasil also contributed to the top-line gains, helping to boost Merck's overall vaccine-related revenue by 33% year over year.",0.9580342173576355,0.021874628961086273,0.02009115181863308,positive,0.936159610748291
17,2019-07-30 06:45:00,CEO Ken Frazier was upbeat about Merck's performance and its prospects.,0.5980018973350525,0.020949311554431915,0.3810487985610962,positive,0.5770525932312012
18,2019-07-30 06:45:00,"Attributing the gains to ""our science-led strategy and execution across our key growth pillars,"" Frazier said that ""we remain confident that our innovative products and significant pipeline opportunities will continue to deliver strong results.""",0.9463744163513184,0.01591632142663002,0.03770928084850311,positive,0.9304580688476562
19,2019-07-30 06:45:00,"Drug stocks like Merck haven't been among the top performers in the Dow Jones Industrial Average during 2019, as the healthcare industry has faced increasing scrutiny from Washington concerning its drug pricing practices.",0.08877594023942947,0.8022781014442444,0.10894594341516495,negative,-0.7135021686553955
20,2019-07-30 06:45:00,Yet Merck is still trying to come up with new treatments to help patients and to make the most of drugs already on the market.,0.6258429288864136,0.014914189465343952,0.35924288630485535,positive,0.6109287142753601
21,2019-07-30 06:45:00,"That strategy has been a winning one over the long haul, and it's likely to be effective no matter what happens with lawmakers trying to implement new healthcare reform efforts.",0.8846628665924072,0.015589701011776924,0.09974739700555801,positive,0.8690731525421143
22,2019-07-30 06:45:00,10 stocks we like better than Merck & Co.,0.4072535037994385,0.02517339400947094,0.5675731301307678,neutral,0.3820801079273224
23,2019-07-30 06:45:00,"When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12617750465869904,0.07430703938007355,0.799515426158905,neutral,0.05187046527862549
24,2019-07-30 06:45:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
25,2019-07-30 06:45:00,"*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Merck & Co. wasn't one of them!",0.18531367182731628,0.016433846205472946,0.798252522945404,neutral,0.16887982189655304
26,2019-07-30 06:45:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
27,2019-07-30 06:45:00,Dan Caplinger has no position in any of the stocks mentioned.,0.01018188614398241,0.043783675879240036,0.9460343718528748,neutral,-0.0336017906665802
28,2019-07-30 06:45:00,The Motley Fool is short shares of Procter & Gamble.,0.044476453214883804,0.4596617817878723,0.49586179852485657,neutral,-0.4151853322982788
29,2019-07-30 06:45:00,The Motley Fool has a disclosure policy.,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
